EP3017811
Apixaban lyfjaform
Status:
EP Einkaleyfi ógilt eftir andmæliEP appl. date:
24.2.2011EP published:
5.12.2018EP application number:
15190823.3
EP translation filed:
4.3.2019Grant published:
15.3.2019EPO information:
European Patent Register
Max expiry date:
23.2.2031Expiry date:
23.2.2025
Title:
APIXABAN FORMULATIONS
Timeline
Today
24.2.2011EP application
5.12.2018EP Publication
4.3.2019Translation submitted
15.3.2019Registration published
23.2.2025Expires
Owner
Name:
Bristol-Myers Squibb Holdings Ireland Unlimited CompanyAddress:
Hinterbergstrasse 16, 6312, Steinhausen, CH
Name:
Pfizer Inc.Address:
235 East 42nd Street, 10017, New York, NY, US
Inventor
Name:
PATEL, JatinAddress:
Princton, NJ New Jersey, US
Name:
FROST, CharlesAddress:
Princton, NJ New Jersey, US
Name:
JIA, JingpinAddress:
Princton, NJ New Jersey, US
Name:
VEMA-VARAPU, ChandraAddress:
Princton, NJ New Jersey, US
Agent
Name:
G.H. Sigurgeirsson ehf.Address:
Borgartúni 26, 105, Reykjavík,
Priority
Number:
308056 PDate:
25.2.2010Country:
US
Classification
Categories:
A61K 9/20, A61K 31/4545, A61P 7/02
Annual fees
Number
Paid
Expires
Payer
Number: 9
Paid: 18.1.2019
Expires: 23.2.2020
Payer: G. H. Sigurgeirsson
Number: 10
Paid: 14.1.2020
Expires: 23.2.2021
Payer: Árnason Faktor ehf.
Number: 11
Paid: 12.1.2021
Expires: 23.2.2022
Payer: Árnason Faktor ehf.
Number: 12
Paid: 5.1.2022
Expires: 23.2.2023
Payer: Árnason Faktor ehf.
Number: 13
Paid: 5.1.2023
Expires: 23.2.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 5.1.2023
Expires: 23.2.2024
Payer: Árnason Faktor ehf.
Number: 13
Paid: 5.1.2023
Expires: 23.2.2024
Payer: Árnason Faktor ehf.
Number: 14
Paid: 9.1.2024
Expires: 23.2.2025
Payer: Árnason Faktor ehf.